Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Phase I Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Preliminary Results of the ITCC-059 Study

Blood (2019) 134 (Supplement_1): 2629.

https://doi.org/10.1182/blood-2019-122411

Published: 2019

Journal Articles

Minimal Residual Disease and IKZF1 As Predictors of Relapse, and Increased Treatment Related Mortality in Down Syndrome Acute Lymphoblastic Leukemia: A Unique and Large International Matched Case-Control Study

Naomi Michels, BSc, Judith M. Boer, PhD, Marta Lopez-Yurda, PhD, Hester A. De Groot-Kruseman, PhD, Vincent van der Velden, PhD, Anthony V. Moorman, Amir Enshaei, PhD, Ajay Vora, Rosemary Sutton, BSc MSc PhD, Toby Trahair, PhD, Luciano Dalla-Pozza, MBBS FRACP, Rob Pieters, MDPhDMSc, Michel C Zwaan, MD PhD, Monique L. Den Boer, PhD

Blood (2019) 134 (Supplement_1): 827.

https://doi.org/10.1182/blood-2019-124290

Published: 2019

Journal Articles

The Level of Circulating Myeloma Cells at Diagnosis Correlates with a Plasma Cell Leukemia-like Phenotype of the Corresponding Myeloma Cells in Bone Marrow

Davine Hofste Op Bruinink, MD, Vincent van der Velden, PhD, Mark van Duin, PhD, Berna Beverloo, PhD, Jeroen te Marvelde, BSc, Chelsea den Hollander, BSc, Rowan Kuiper, MSc, Michel Delforge, MDPhD, Martin H van Vliet, PhD, Niels WCJ van de Donk, MDPhD, Hervé Avet-Loiseau, MDPhD, Philippe Moreau, MDPhD, Pieter Sonneveld, MDPhD

Blood (2017) 130 (Supplement 1): 4368.

https://doi.org/10.1182/blood.V130.Suppl_1.4368.4368

Published: 2017

Journal Articles

Targeted Deep Sequencing of GATA1 more Sensitively Identifies Transient Myeloproliferative Disorder in Neonates with Down Syndrome

Bianca F Goemans, MD PhD, Sanne Noort, MD MSc, Marjolein Blink, MD PhD, Ko van Wouwe, MD PhD, Gertjan J.L. Kaspers, MD PhD, Valerie de Haas, MD PhD, Wouter J.W. Kollen, MD PhD, Vincent van der Velden, PhD, Tanja A. Gruber, MD PhD, Michel Zwaan, MD PhD

Blood (2017) 130 (Supplement 1): 2919.

https://doi.org/10.1182/blood.V130.Suppl_1.2919.2919

Published: 2017

Journal Articles

Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study

Blood (2017) 130 (Supplement 1): 2606.

https://doi.org/10.1182/blood.V130.Suppl_1.2606.2606

Published: 2017

Journal Articles

Genetic Aberrations As Putative MRD Targets in Childhood Acute Myeloid Leukaemia

Edwin Sonneveld, PhD, Valerie De Haas, Gertjan Kaspers, MD PhD, C. Michel Zwaan, Eveline Bont, MD PhD, Vincent van der Velden, PhD

Blood (2014) 124 (21): 2331.

https://doi.org/10.1182/blood.V124.21.2331.2331

Published: 2014

Journal Articles

Comparison of MRD Monitoring By IG/TR Rearrangement and BCR/ABL1 Transcript in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with Imatinib in the Esphall Study

Blood (2014) 124 (21): 3782.

https://doi.org/10.1182/blood.V124.21.3782.3782

Published: 2014

Journal Articles

Ikaros Is a Frequently Affected Hematopoietic Differentiation Factor in Pediatric Relapse-Prone Precursor B-Cell Acute Lymphoblastic Leukemia

Roland P. Kuiper, PhD, Frank N. van Leeuwen, PhD, Vincent van der Velden, Simon V. van Reijmersdal, Jeltje de Vries, PhD, Suzanne T.M. Keijzers-Vloet, Jayne Hehir-Kwa, E. van Wering, Jacques JM van Dongen, Ph.D, Peter M. Hoogerbrugge, Ad Geurts van Kessel

Blood (2008) 112 (11): 4144.

https://doi.org/10.1182/blood.V112.11.4144.4144

Published: 2008

Journal Articles

Chromosome 14 Copy Number-Dependent IGH Gene Rearrangement Patterns in High Hyperdiploid Childhood B Cell Precursor ALL: Implications for Leukemia Biology and Minimal Residual Disease Analysis.

Eva Csinady, Vincent van der Velden, Ulrike Kaindl, Ruth Joas, Jelteje de Vries, Berna Beverloo, Jacques van Dongen, Georg Mann, Oskar A. Haas, Renate Panzer-Grümayer

Blood (2008) 112 (11): 1517.

https://doi.org/10.1182/blood.V112.11.1517.1517

Published: 2008

Journal Articles

Standardization of WT1 mRNA Quantification for Minimal Residual Disease (MRD) Monitoring in Acute Leukemia Patients: A European LeukemiaNet Concerted Action.

Enrico Gottardi, Daniela Cilloni, MD, Sarah Daly, S. Green, Niels Pallisgaard, P. Hokland, MD, M. Ostergaard, C. Nyvold, J. Nomdedeu, MD, Fabrizio Pane, MD, Susanne Schnittger, Vincent Van der Velden, Kalid Tobal, Y. Yin Jal, Fabienne Hermitte, Teo De Witte, R. Hehlmann, Giuseppe Saglio, MD, David Grimwade, MD

Blood (2005) 106 (11): 3295.

https://doi.org/10.1182/blood.V106.11.3295.3295

Published: 2005

Journal Articles

Clonal Changes Are Frequent in Relapsed TEL-AML1+ ALL and Predominate in Young Children.

Renate Panzer-Grümayer, Giovanni Cazzaniga, Vincent van der Velden, Laura del Giudice, Martina Peham, Conny Eckert, Andre Schrauder, Jochen Harbott, Guiseppe Basso, Andrea Biondi, Jacques van Dongen, Oskar Haas, Helmut Gadner

Blood (2004) 104 (11): 320.

https://doi.org/10.1182/blood.V104.11.320.320

Published: 2004

NARROW

A Phase I Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Preliminary Results of the ITCC-059 Study

Minimal Residual Disease and IKZF1 As Predictors of Relapse, and Increased Treatment Related Mortality in Down Syndrome Acute Lymphoblastic Leukemia: A Unique and Large International Matched Case-Control Study

The Level of Circulating Myeloma Cells at Diagnosis Correlates with a Plasma Cell Leukemia-like Phenotype of the Corresponding Myeloma Cells in Bone Marrow

Targeted Deep Sequencing of GATA1 more Sensitively Identifies Transient Myeloproliferative Disorder in Neonates with Down Syndrome

Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study

Genetic Aberrations As Putative MRD Targets in Childhood Acute Myeloid Leukaemia

Comparison of MRD Monitoring By IG/TR Rearrangement and BCR/ABL1 Transcript in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with Imatinib in the Esphall Study

Ikaros Is a Frequently Affected Hematopoietic Differentiation Factor in Pediatric Relapse-Prone Precursor B-Cell Acute Lymphoblastic Leukemia

Chromosome 14 Copy Number-Dependent IGH Gene Rearrangement Patterns in High Hyperdiploid Childhood B Cell Precursor ALL: Implications for Leukemia Biology and Minimal Residual Disease Analysis.

Standardization of WT1 mRNA Quantification for Minimal Residual Disease (MRD) Monitoring in Acute Leukemia Patients: A European LeukemiaNet Concerted Action.

Clonal Changes Are Frequent in Relapsed TEL-AML1+ ALL and Predominate in Young Children.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only